![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: TBC1D9B |
Gene summary for TBC1D9B |
![]() |
Gene information | Species | Human | Gene symbol | TBC1D9B | Gene ID | 23061 |
Gene name | TBC1 domain family member 9B | |
Gene Alias | GRAMD9B | |
Cytomap | 5q35.3 | |
Gene Type | protein-coding | GO ID | GO:0006810 | UniProtAcc | B3KM54 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
23061 | TBC1D9B | LZE4T | Human | Esophagus | ESCC | 8.73e-05 | 1.35e-01 | 0.0811 |
23061 | TBC1D9B | LZE7T | Human | Esophagus | ESCC | 1.35e-03 | 1.99e-01 | 0.0667 |
23061 | TBC1D9B | LZE8T | Human | Esophagus | ESCC | 6.49e-08 | 2.70e-01 | 0.067 |
23061 | TBC1D9B | LZE24T | Human | Esophagus | ESCC | 1.99e-13 | 4.11e-01 | 0.0596 |
23061 | TBC1D9B | LZE6T | Human | Esophagus | ESCC | 2.59e-05 | 1.84e-01 | 0.0845 |
23061 | TBC1D9B | P1T-E | Human | Esophagus | ESCC | 3.00e-07 | 4.12e-01 | 0.0875 |
23061 | TBC1D9B | P2T-E | Human | Esophagus | ESCC | 1.49e-28 | 4.24e-01 | 0.1177 |
23061 | TBC1D9B | P4T-E | Human | Esophagus | ESCC | 1.72e-16 | 2.96e-01 | 0.1323 |
23061 | TBC1D9B | P5T-E | Human | Esophagus | ESCC | 1.75e-22 | 3.71e-01 | 0.1327 |
23061 | TBC1D9B | P8T-E | Human | Esophagus | ESCC | 1.24e-15 | 1.98e-01 | 0.0889 |
23061 | TBC1D9B | P9T-E | Human | Esophagus | ESCC | 6.82e-12 | 2.77e-01 | 0.1131 |
23061 | TBC1D9B | P10T-E | Human | Esophagus | ESCC | 1.33e-20 | 3.50e-01 | 0.116 |
23061 | TBC1D9B | P11T-E | Human | Esophagus | ESCC | 2.04e-14 | 5.96e-01 | 0.1426 |
23061 | TBC1D9B | P12T-E | Human | Esophagus | ESCC | 7.70e-21 | 3.72e-01 | 0.1122 |
23061 | TBC1D9B | P15T-E | Human | Esophagus | ESCC | 1.53e-23 | 5.45e-01 | 0.1149 |
23061 | TBC1D9B | P16T-E | Human | Esophagus | ESCC | 1.74e-21 | 3.10e-01 | 0.1153 |
23061 | TBC1D9B | P17T-E | Human | Esophagus | ESCC | 6.32e-07 | 4.42e-01 | 0.1278 |
23061 | TBC1D9B | P19T-E | Human | Esophagus | ESCC | 1.32e-07 | 7.68e-01 | 0.1662 |
23061 | TBC1D9B | P20T-E | Human | Esophagus | ESCC | 2.62e-13 | 3.23e-01 | 0.1124 |
23061 | TBC1D9B | P21T-E | Human | Esophagus | ESCC | 1.46e-25 | 4.80e-01 | 0.1617 |
Page: 1 2 3 4 5 6 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:004308715 | Esophagus | ESCC | regulation of GTPase activity | 183/8552 | 348/18723 | 5.34e-03 | 2.00e-02 | 183 |
GO:004308710 | Oral cavity | OSCC | regulation of GTPase activity | 165/7305 | 348/18723 | 7.94e-04 | 4.27e-03 | 165 |
GO:004308713 | Prostate | Tumor | regulation of GTPase activity | 88/3246 | 348/18723 | 1.04e-04 | 1.00e-03 | 88 |
GO:004354713 | Prostate | Tumor | positive regulation of GTPase activity | 60/3246 | 255/18723 | 6.87e-03 | 3.11e-02 | 60 |
GO:004308718 | Thyroid | PTC | regulation of GTPase activity | 148/5968 | 348/18723 | 1.63e-05 | 1.71e-04 | 148 |
GO:004354714 | Thyroid | PTC | positive regulation of GTPase activity | 103/5968 | 255/18723 | 2.38e-03 | 1.25e-02 | 103 |
GO:004308719 | Thyroid | ATC | regulation of GTPase activity | 153/6293 | 348/18723 | 3.24e-05 | 2.68e-04 | 153 |
GO:004354715 | Thyroid | ATC | positive regulation of GTPase activity | 106/6293 | 255/18723 | 4.58e-03 | 1.89e-02 | 106 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
TBC1D9B | SNV | Missense_Mutation | rs199637229 | c.3154N>A | p.Ala1052Thr | p.A1052T | Q66K14 | protein_coding | deleterious(0) | probably_damaging(0.978) | TCGA-B5-A3FC-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
TBC1D9B | SNV | Missense_Mutation | novel | c.2909N>T | p.Ala970Val | p.A970V | Q66K14 | protein_coding | tolerated(0.31) | benign(0) | TCGA-B5-A3FC-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
TBC1D9B | SNV | Missense_Mutation | c.827C>T | p.Ala276Val | p.A276V | Q66K14 | protein_coding | tolerated(0.51) | possibly_damaging(0.495) | TCGA-D1-A103-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
TBC1D9B | SNV | Missense_Mutation | c.250N>G | p.Thr84Ala | p.T84A | Q66K14 | protein_coding | deleterious(0.03) | possibly_damaging(0.867) | TCGA-D1-A15X-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
TBC1D9B | SNV | Missense_Mutation | novel | c.2967G>T | p.Glu989Asp | p.E989D | Q66K14 | protein_coding | tolerated(0.25) | benign(0.003) | TCGA-D1-A175-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | paclitaxel | SD |
TBC1D9B | SNV | Missense_Mutation | novel | c.1067A>G | p.Asp356Gly | p.D356G | Q66K14 | protein_coding | deleterious(0.01) | benign(0.215) | TCGA-D1-A175-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | paclitaxel | SD |
TBC1D9B | SNV | Missense_Mutation | c.1166N>A | p.Arg389Lys | p.R389K | Q66K14 | protein_coding | tolerated(0.47) | benign(0.023) | TCGA-D1-A17Q-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
TBC1D9B | SNV | Missense_Mutation | rs777232858 | c.997G>A | p.Ala333Thr | p.A333T | Q66K14 | protein_coding | tolerated(0.33) | benign(0.053) | TCGA-DF-A2KU-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | Unknown | I/II | Unknown | Unknown | SD |
TBC1D9B | SNV | Missense_Mutation | novel | c.3269N>G | p.Glu1090Gly | p.E1090G | Q66K14 | protein_coding | tolerated(0.28) | benign(0) | TCGA-DF-A2KV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
TBC1D9B | SNV | Missense_Mutation | rs745957333 | c.2263N>A | p.Asp755Asn | p.D755N | Q66K14 | protein_coding | tolerated(0.31) | benign(0.312) | TCGA-E6-A1LX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 9 10 11 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |